Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus.

Bixler SL, Bocan TM, Wells J, Wetzel KS, Van Tongeren SA, Dong L, Garza NL, Donnelly G, Cazares LH, Nuss J, Soloveva V, Koistinen KA, Welch L, Epstein C, Liang LF, Giesing D, Lenk R, Bavari S, Warren TK.

Antiviral Res. 2018 Mar;151:97-104. doi: 10.1016/j.antiviral.2017.12.021. Epub 2017 Dec 28.

2.

Intracellular conversion and in vivo dose response of favipiravir (T-705) in rodents infected with Ebola virus.

Bixler SL, Bocan TM, Wells J, Wetzel KS, Van Tongeren SA, Garza NL, Donnelly G, Cazares LH, Soloveva V, Welch L, Epstein C, Liang LF, Giesing D, Lenk R, Bavari S, Warren TK.

Antiviral Res. 2018 Mar;151:50-54. doi: 10.1016/j.antiviral.2017.12.020. Epub 2017 Dec 28.

3.

Favipiravir inhibits acetaminophen sulfate formation but minimally affects systemic pharmacokinetics of acetaminophen.

Zhao Y, Harmatz JS, Epstein CR, Nakagawa Y, Kurosaki C, Nakamura T, Kadota T, Giesing D, Court MH, Greenblatt DJ.

Br J Clin Pharmacol. 2015 Nov;80(5):1076-85. doi: 10.1111/bcp.12644. Epub 2015 Jun 8.

4.

Continuous intravesical lidocaine treatment for interstitial cystitis/bladder pain syndrome: safety and efficacy of a new drug delivery device.

Nickel JC, Jain P, Shore N, Anderson J, Giesing D, Lee H, Kim G, Daniel K, White S, Larrivee-Elkins C, Lekstrom-Himes J, Cima M.

Sci Transl Med. 2012 Jul 18;4(143):143ra100. doi: 10.1126/scitranslmed.3003804.

5.

Alkalinized lidocaine and heparin provide immediate relief of pain and urgency in patients with interstitial cystitis.

Parsons CL, Zupkas P, Proctor J, Koziol J, Franklin A, Giesing D, Davis E, Lakin CM, Kahn BS, Garner WJ.

J Sex Med. 2012 Jan;9(1):207-12. doi: 10.1111/j.1743-6109.2011.02542.x. Epub 2011 Nov 14.

PMID:
22082303
6.

A pharmacophore hypothesis for P-glycoprotein substrate recognition using GRIND-based 3D-QSAR.

Cianchetta G, Singleton RW, Zhang M, Wildgoose M, Giesing D, Fravolini A, Cruciani G, Vaz RJ.

J Med Chem. 2005 Apr 21;48(8):2927-35.

PMID:
15828831
7.
8.

Pharmacokinetics of 5-aminosalicylic acid from controlled-release capsules in man.

Yu DK, Morrill B, Eichmeier LS, Lanman RC, Lanman MB, Giesing DH, Weir SJ.

Eur J Clin Pharmacol. 1995;48(3-4):273-7.

PMID:
7589054
9.

Single and multiple oral dose pharmacokinetics of clentiazem in normal volunteers.

Bhargava VO, Shah AK, Weir SJ, Nordbrock EE, Giesing DH.

J Clin Pharmacol. 1993 May;33(5):439-43.

PMID:
8331200
10.

Pharmacokinetics of clentiazem after intravenous and oral administration in healthy subjects.

Shah AK, Bhargava VO, Weir SJ, Giesing DH.

J Clin Pharmacol. 1993 Apr;33(4):354-9.

PMID:
8473551
11.
12.

Pharmacokinetics of diltiazem and propranolol when administered alone and in combination.

Dimmitt DC, Yu DK, Elvin AT, Giesing DH, Lanman RC.

Biopharm Drug Dispos. 1991 Oct;12(7):515-23.

PMID:
1932613
13.

Effect of food coadministration on 5-aminosalicylic acid oral suspension bioavailability.

Yu DK, Elvin AT, Morrill B, Eichmeier LS, Lanman RC, Lanman MB, Giesing DH.

Clin Pharmacol Ther. 1990 Jul;48(1):26-33.

PMID:
2369807
14.

Pharmacokinetics of nitroglycerin and metabolites in humans following oral dosing.

Yu DK, Williams RL, Benet LZ, Lin ET, Giesing DH.

Biopharm Drug Dispos. 1988 Nov-Dec;9(6):557-65.

PMID:
3147725
15.

Pharmacokinetics of dothiepin in humans: a single dose dose-proportionality study.

Yu DK, Dimmitt DC, Lanman RC, Giesing DH.

J Pharm Sci. 1986 Jun;75(6):582-5.

PMID:
3735103
16.

In vitro adsorption of bile salts and aspirin to sucralfate.

Graham DY, Sackman JW, Giesing DH, Runser DJ.

Dig Dis Sci. 1984 May;29(5):402-6.

PMID:
6546915
17.

Effect of food and antacid on binding of sucralfate to normal and ulcerated gastric and duodenal mucosa in rats.

Giesing DH, Bighley LD, Iles RL.

J Clin Gastroenterol. 1981;3(Suppl 2):111-6.

PMID:
6895642

Supplemental Content

Loading ...
Support Center